Increased infiltration and tolerised antigen-specific CD8+ TEM cells in tumor but not peripheral blood have no impact on survival of HCMV+ glioblastoma patients
Human cytomegalovirus (HCMV) antigens in glioblastoma (GBM) present opportunities for personalised immunotherapy. However, their presence in GBM tissue is still under debate, and evidence of their impact on functional immune responses and prognosis is sparse. Here, we investigated the presence of pp...
Main Authors: | M. Bahador, A. Gras Navarro, M.A. Rahman, M. Dominguez-Valentin, S. Sarowar, E. Ulvestad, G. Njølstad, S.A. Lie, E.K. Kristoffersen, E. Bratland, M. Chekenya |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-08-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2017.1336272 |
Similar Items
-
Role of Immunogenetics in the Outcome of HCMV Infection: Implications for Ageing
by: Anna Aiello, et al.
Published: (2019-02-01) -
Comparison of HCMV DNA load and antigenemia results in hematopoietic transplant recipients based on GVHD grade
by: Pajand O, et al.
Published: (2007-05-01) -
A diverse repertoire of CD4 T cells targets the immediate-early 1 protein of human cytomegalovirus
by: Stefanie eAmeres, et al.
Published: (2015-11-01) -
US28: HCMV’s Swiss Army Knife
by: Benjamin A. Krishna, et al.
Published: (2018-08-01) -
Differential outcome of neurological HCMV infection in two hematopoietic stem cell transplant recipients
by: Colombo Anna, et al.
Published: (2012-10-01)